INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
77 hedge funds and large institutions have $15.8M invested in Infinity Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 26 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less capital invested
Capital invested by funds: $38.6M → $15.8M (-$22.8M)
Holders
77
Holding in Top 10
–
Calls
$227K
Puts
$61K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$265K | |
| 3 | +$202K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$70.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$62.7K |
Top Sellers
| 1 | -$2.7M | |
| 2 | -$990K | |
| 3 | -$521K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$384K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$359K |